Mental Health News and Research

Latest Mental Health News and Research

Humana introduces senior-friendly dance pad video game at Kissimmee Guidance Center

What: Humana (http://www.humana.com), Florida's largest Medicare health benefits provider, is introducing Dancetown (http://humanagames.com), a senior-friendly dance pad video game at its Kissimmee Guidance Center on Tues., Dec. 8 at 1 p.m.

5 Dec 2009

AES: Progress in epilepsy management not reached millions of people around the world

Substantial progress has been made over the last 15 years in the healthcare community's ability to diagnose and treat epilepsy and its complications. Yet this progress in epilepsy management has not reached most of the 50 million people around the world, including many of the nearly three million people in the United States who have the disorder.

5 Dec 2009

Health experts available to speak about health care reform

Garson helped originate and draft the "Health Partnership Act" (S. 325 and H.R. 5606), which funds grants to states for innovations to improve coverage for the uninsured, quality and efficiency.

5 Dec 2009

Health experts address treatment gap in epilepsy management at AES Annual Meeting

5 Dec 2009

Aetna Medicare Advantage members now have access to MidState Medical Center and Windham Hospital

Aetna (NYSE:ΑET) announced today that beginning January 1, 2010, its Medicare Advantage members will have access to MidState Medical Center and Windham Hospital as part of Aetna’s Medicare network of participating health care facilities in Connecticut.

5 Dec 2009

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

Elan Drug Technologies, a business unit of Elan Corporation, plc announced that Janssen-Cilag has submitted a Marketing Authorisation Application (MAA) to the European Medicines Agency for paliperidone palmitate for the treatment of Schizophrenia.

4 Dec 2009

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old.

4 Dec 2009

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

Depression, anxiety disorder, bipolar disorder, Attention Deficit Hyperactivity Disorder (ADHD), sleep disorder and migraine: These are among the comorbidities reported to occur more often in people who said they had been diagnosed with epilepsy versus those without an epilepsy diagnosis, according to a survey of approximately 173,000 households across the U.S.

4 Dec 2009

FDA approves once-daily SEROQUEL XR Extended Release Tablets

AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR® (quetiapine fumarate) Extended Release Tablets as adjunctive (add-on) treatment to antidepressants in adults with Major Depressive Disorder (MDD).

4 Dec 2009

New smokers more likely to use menthol cigarettes

Menthol cigarette use is higher among persons who started smoking in the past year (44.6 percent) than among longer-term smokers (31.8 percent) according to a new study by the Substance Abuse and Mental Health Services Administration (SAMHSA).

4 Dec 2009

Research study investigates how music therapy can help mentally ill children and young people

Queen's University Belfast is to play a major role in the biggest trial ever conducted to investigate how music therapy can help children and young people with severe mental health problems.

4 Dec 2009

African American and Hispanic adults smoking menthol cigarettes less likely to quit smoking, says study

African American and Hispanic adults who smoke menthol cigarettes may be less likely to quit smoking than those who smoke regular cigarettes, a new study by researchers at the UMDNJ-School of Public Health has found. The report, published in the December issue of Preventive Medicine, is believed to be the first to use national statistics to examine the association between menthol cigarettes and smoking cessation among adults.

4 Dec 2009

Climate change can cause major impact on global mental health

Leading mental health researchers are warning that some of the most important health consequences of climate change will be on mental health, yet this issue is unlikely to be given much attention at the UN climate change conference in Copenhagen next week.

4 Dec 2009

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

Rules-Based Medicine, Inc. (RBM) today announced that Psynova Neurotech Limited (Cambridge UK), a majority-owned subsidiary of RBM, has executed an exclusive research and licensing agreement with Roche to collaborate on the discovery, development, validation and commercialization of diagnostic immunoassays to aid the clinical development and commercial differentiation of novel treatments for schizophrenia.

3 Dec 2009

EU study to promote health and reduce risk-taking and self-destructive behavior in young people

At the beginning of 2010, the Child and Adolescent Psychiatry Department at the Center for Psychosocial Medicine at Heidelberg University Hospital will conduct a study named "Saving and Empowering Young Lives in Europe (SEYLE) - promoting the health of young people through the prevention of risk-taking and self-destructive behavior" in cooperation with twelve centers in other EU countries and Israel.

3 Dec 2009

Macular Health eye vitamin supplement improves visual acuity

Adults are more likely to lose their vision than be diagnosed with cancer. For adults 65 and over, the odds of losing vision are one in three, whereas the odds of a man developing prostate cancer are one in six and odds of a woman developing breast cancer are one in nine. Vision loss threatens the overall health of aging adults by increasing the risk of injuries, depression and inability to complete daily tasks.

3 Dec 2009

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

Dr. Julio Montaner - Director, British Columbia Centre for Excellence in HIV/AIDS (BC-CfE), and President, International AIDS Society - congratulated Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH), for taking a leadership role in the evaluation of the "Seek and Treat" strategy originally developed at the BC-CfE.

3 Dec 2009

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

AstraZeneca and Targacept, Inc. today announced a collaboration and license agreement for the global development and commercialization of TC-5214, Targacept’s late-stage investigational product for major depressive disorder (MDD).

3 Dec 2009

NHLBI approves award of 13 contracts to improve asthma control

The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has approved the award of 13 contracts to local organizations across the country to develop, implement, and test science-based approaches to improve asthma control using evidence-based national guidelines for diagnosing and managing asthma.

3 Dec 2009

AclarusDx Alzheimer’s test now available as RUO product

ExonHit Therapeutics is pleased to announce that AclarusDx™ Alzheimer’s test (formerly known as EHT Dx21), its blood-based test for the detection of Alzheimer’s disease (AD), is now available as a Research Use Only (RUO) product for pharmaceutical companies and leading academic centers conducting clinical trials in Alzheimer’s disease.

3 Dec 2009

Mental Health News and Research

Latest Mental Health News and Research

Humana introduces senior-friendly dance pad video game at Kissimmee Guidance Center

AES: Progress in epilepsy management not reached millions of people around the world

Health experts available to speak about health care reform

Health experts address treatment gap in epilepsy management at AES Annual Meeting

Aetna Medicare Advantage members now have access to MidState Medical Center and Windham Hospital

Janssen-Cilag submits MAA to the European Medicines Agency for paliperidone palmitate

FDA approves Zyprexa in tablet form for schizophrenia and manic treatment

Analysis explores the importance of CNS-related conditions and their impact on epilepsy management

FDA approves once-daily SEROQUEL XR Extended Release Tablets

New smokers more likely to use menthol cigarettes

Research study investigates how music therapy can help mentally ill children and young people

African American and Hispanic adults smoking menthol cigarettes less likely to quit smoking, says study

Climate change can cause major impact on global mental health

Psynova Neurotech, Roche collaborate in development of diagnostic immunoassays for schizophrenia treatment

EU study to promote health and reduce risk-taking and self-destructive behavior in young people

Macular Health eye vitamin supplement improves visual acuity

NIDA funds proposed 'seek and treat' strategy in the fight against HIV/AIDS

AstraZeneca and Targacept enter into agreement to develop and commercialize TC-5214

NHLBI approves award of 13 contracts to improve asthma control

AclarusDx Alzheimer’s test now available as RUO product

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Mental Health News and Research

Latest Mental Health News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Shaping the future of lab automation through AI and robotics

Newsletters you may be interested in